Monday, 27 January 2020

Biocon Biologics eyes $200M, plans IPO in 2 years: Kiran Mazumdar-Shaw

With the funding, Biocon is looking to fund its research and development, and infuse capital to expand its biosimilars business

No comments:

Post a Comment